530 East 74th StreetNew York, NY 10021
Overview of Dr. Salles
Dr. Gilles Salles is an oncologist based in New York, NY, with a subspecialty in hematologic oncology, particularly experienced in lymphoma. He graduated from Université Claude Bernard Lyon in 1989. His recent publications focus on lymphoma-related topics, including CAR T-cell therapy and treatment strategies for diffuse large B-cell and follicular lymphoma, published in top tier journals such as New England Journal of Medicine, JCO, Blood and others. Dr. Salles is actively involved in multiple trials concerning treatments for various types of lymphoma, serving as a contact and principal investigator for studies exploring novel therapeutic combinations.
Education & Training
Université Claude Bernard LyonClass of 1989
Certifications & Licensure
NY State Medical License 2021 - 2027
Awards, Honors, & Recognition
- T Howard Lee Keynote Lecture 20th Annual Indy Hematology Review, 2023
- Steven Greenberg Chair MKS, 2021
- Clinicak Keynote Speaker 18th International Ultmann Chicago Lymphoma Symposium, 2021
- Join now to see all
Clinical Trials
- A Study of Mosunetuzumab in People With Follicular Lymphoma Start of enrollment: 2022 May 27
Roles: Contact
- A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma. Start of enrollment: 2020 Jun 11
- An Open-Label Study Comparing Glofitamab and Polatuzumab Vedotin + Rituximab, Cyclophosphamide, Doxorubicin, and Prednisone Versus Pola-R-CHP in Previously Untreated Patients With Large B-Cell Lymphoma Start of enrollment: 2023 Sep 18
- Join now to see all
Publications & Presentations
PubMed
- T-ICAHT: Grading and Prognostic Impact of Thrombocytopenia After CAR T-cell Therapy.Kai Rejeski, Jaime Sanz, Teng Fei, Monica S Nair, Hamza Hashmi
Blood. 2025-04-21 - CAR T-cell therapy response varies by extranodal disease site in large B-cell lymphoma.Alejandro Luna, Sean M Devlin, Kai Rejeski, Jessica R Flynn, Magdalena Corona
Blood Cancer Journal. 2025-04-14 - Treatment failure patterns in early versus late introduction of CAR T-cell therapy in large B-cell lymphoma.Magdalena Corona, Andrew Ip, Samantha Brown, Alejandro Luna, Hazim Khatib
Bone Marrow Transplantation. 2025-04-01
Press Mentions
DLBCL: Polatuzumab Vedotin Enhances Progression-Free SurvivalDecember 17th, 2021- DLBCL: PFS but No OS Benefit with Polatuzumab-Vedotin Add-OnDecember 17th, 2021
- Incyte : MorphoSys and Incyte Announce Three-Year Results from Phase 2 L-MIND Study of Tafasitamab in Combination with Lenalidomide for the Treatment of Relapsed or Refractory DLBCLJune 9th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
